CellCyte , das war´s - CellCyte stops paying its remaining employees - 500 Beiträge pro Seite
eröffnet am 22.08.08 12:07:35 von
neuester Beitrag 22.08.08 12:20:57 von
neuester Beitrag 22.08.08 12:20:57 von
Beiträge: 2
ID: 1.143.694
ID: 1.143.694
Aufrufe heute: 0
Gesamt: 659
Gesamt: 659
Aktive User: 0
Top-Diskussionen
Titel | letzter Beitrag | Aufrufe |
---|---|---|
vor 12 Minuten | 2969 | |
vor 17 Minuten | 1977 | |
08.05.24, 11:56 | 1162 | |
11.05.24, 11:52 | 808 | |
heute 07:40 | 724 | |
vor 27 Minuten | 700 | |
vor 16 Minuten | 663 | |
vor 25 Minuten | 551 |
Meistdiskutierte Wertpapiere
Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
---|---|---|---|---|---|---|---|
1. | 2. | 18.765,30 | -0,05 | 96 | |||
2. | 1. | 0,2000 | -7,83 | 53 | |||
3. | 8. | 10,800 | +4,45 | 32 | |||
4. | 3. | 157,08 | +0,40 | 26 | |||
5. | 4. | 0,1601 | -3,61 | 22 | |||
6. | 6. | 0,2880 | -3,36 | 20 | |||
7. | 5. | 2,3750 | +0,13 | 18 | |||
8. | 9. | 19,400 | +19,69 | 14 |
LK6 das wars, noch nichts über die Ticker dazu gekommen.
http://seattlepi.nwsource.com/business/375651_cellcyte20.htm…
Troubled CellCyte Genetics of Bothell halts staff paychecks
By JOSEPH TARTAKOFF
P-I REPORTER
Stem cell company CellCyte Genetics Bothell says it does not have enough cash to fund its operations beyond the next month and has stopped paying its employees.
In a filing with the Securities and Exchange Commission, CellCyte says it has $215,287 in cash but expects to spend $2.5 million over the next year.
Last fall, the company said it had 17 employees and planned to have 30 within a year.
"Subsequent to the reporting period ended June 30, 2008, the company terminated some of its employees and placed the remaining employees on a salary accrual basis, so that no employee is currently receiving compensation," the company said in its quarterly filing with the SEC.
"Until and unless the company is able to secure financing, either through a sale of equity, debt, or a combination thereof, its activities will be curtailed and the employees will not receive compensation.
"Unless the company is able to secure financing, it will be unable to continue its research and may be required to cease operations."
A spokeswoman said Tuesday evening that she could not comment.
http://seattlepi.nwsource.com/business/375651_cellcyte20.htm…
Troubled CellCyte Genetics of Bothell halts staff paychecks
By JOSEPH TARTAKOFF
P-I REPORTER
Stem cell company CellCyte Genetics Bothell says it does not have enough cash to fund its operations beyond the next month and has stopped paying its employees.
In a filing with the Securities and Exchange Commission, CellCyte says it has $215,287 in cash but expects to spend $2.5 million over the next year.
Last fall, the company said it had 17 employees and planned to have 30 within a year.
"Subsequent to the reporting period ended June 30, 2008, the company terminated some of its employees and placed the remaining employees on a salary accrual basis, so that no employee is currently receiving compensation," the company said in its quarterly filing with the SEC.
"Until and unless the company is able to secure financing, either through a sale of equity, debt, or a combination thereof, its activities will be curtailed and the employees will not receive compensation.
"Unless the company is able to secure financing, it will be unable to continue its research and may be required to cease operations."
A spokeswoman said Tuesday evening that she could not comment.
Mitarbeiter können sie also nichtmal mehr bezahlen. der laden wird stumpf eingestellt.
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
96 | ||
53 | ||
32 | ||
26 | ||
22 | ||
20 | ||
18 | ||
14 | ||
13 | ||
10 |
Wertpapier | Beiträge | |
---|---|---|
10 | ||
8 | ||
8 | ||
7 | ||
7 | ||
6 | ||
6 | ||
6 | ||
6 | ||
6 |